Biopharmaceutical sector rose 0.41%, Yaben Chemical rose 20.01% to top the list – yqqlm Post date May 11, 2022 — 16:45 Post Lock Read More 2.389 billion yuan of main funds withdraw from the pharmaceutical and biological sector today_ Oriental Fortune Net Post date May 10, 2022 — 18:18 Post Lock Read More The main trend: the net inflow of extra-large orders on May 10 was 7.117 billion yuan_Oriental Fortune Net Post date May 10, 2022 — 18:16 Post Lock Read More Lukang Pharmaceutical (600789.SH) net profit in the first quarter was 44.5889 million yuan, a year-on-year decrease of 7.02% – yqqlm Post date April 29, 2022 — 21:23 Post Lock Read More Lukang Pharmaceutical (600789.SH) net profit in the first quarter was 44.5889 million yuan, a year-on-year decrease of 7.02% Post date April 29, 2022 — 21:23 Post Lock Read More The net outflow of the pharmaceutical and biological industry today is 1.164 billion yuan, and the net outflow of 5 shares exceeds 100 million yuan_Oriental Fortune Net Post date April 27, 2022 — 17:37 Post Lock Read More 213 injection varieties have been "reviewed", and there are 100 varieties that meet the requirements of centralized procurement Post date April 27, 2022 — 15:02 Post Lock Read More Attention 250,000 shareholders! The last day of allotment, improper operation or loss! Stocks Financial World Post date April 20, 2022 — 12:38 Post Lock Read More Lukang Pharmaceutical (600789): Independent Opinions of Lukang Pharmaceutical Independent Directors on Matters Related to the Ninth (Interim) Meeting of the Tenth Board of Directors- CFi.CN Zhongcai.com Post date April 19, 2022 — 20:10 Post Lock Read More Lukang Pharmaceutical (600789): Resolution of the 9th (Provisional) Meeting of the Tenth Supervisory Committee of Lukang Pharmaceutical- CFi.CN Zhongcai Network Post date April 19, 2022 — 20:10 Post Lock Read More Lukang Pharma (600789): Lukang Pharma's Explanation on the Revision of the Company's Adjustment of the Company's Allotment and Public Issuance of Securities Plan, Pre-plan, and Feasibility Analysis Report on the Use of Raised Funds- CFi.CN Zhongcai Network Post date April 19, 2022 — 20:10 Post Lock Read More Lukang Pharmaceutical (600789): Feasibility Analysis Report of Lukang Pharmaceutical's 2021 Annual Allotment Raised Funds (Revised Draft) CFi.CN Zhongcai Network Post date April 19, 2022 — 20:10 Post Lock Read More Lukang Pharmaceutical (600789): Lukang Pharmaceutical's Reply to the Feedback on the Allotment Application Documents (Revised Draft) CFi.CN Zhongcai Network Post date April 19, 2022 — 20:09 Post Lock Read More Lukang Pharmaceutical: Ceftriaxone Sodium for Injection Passes Consistency Evaluation of Generic Drugs Post date April 13, 2022 — 20:08 Post Lock Read More [Market] 1.6 billion oral hypoglycemic drugs, Lukang has reviewed it. Post date April 12, 2022 — 19:23 Post Lock Read More
2.389 billion yuan of main funds withdraw from the pharmaceutical and biological sector today_ Oriental Fortune Net Post date May 10, 2022 — 18:18 Post Lock Read More The main trend: the net inflow of extra-large orders on May 10 was 7.117 billion yuan_Oriental Fortune Net Post date May 10, 2022 — 18:16 Post Lock Read More Lukang Pharmaceutical (600789.SH) net profit in the first quarter was 44.5889 million yuan, a year-on-year decrease of 7.02% – yqqlm Post date April 29, 2022 — 21:23 Post Lock Read More Lukang Pharmaceutical (600789.SH) net profit in the first quarter was 44.5889 million yuan, a year-on-year decrease of 7.02% Post date April 29, 2022 — 21:23 Post Lock Read More The net outflow of the pharmaceutical and biological industry today is 1.164 billion yuan, and the net outflow of 5 shares exceeds 100 million yuan_Oriental Fortune Net Post date April 27, 2022 — 17:37 Post Lock Read More 213 injection varieties have been "reviewed", and there are 100 varieties that meet the requirements of centralized procurement Post date April 27, 2022 — 15:02 Post Lock Read More Attention 250,000 shareholders! The last day of allotment, improper operation or loss! Stocks Financial World Post date April 20, 2022 — 12:38 Post Lock Read More Lukang Pharmaceutical (600789): Independent Opinions of Lukang Pharmaceutical Independent Directors on Matters Related to the Ninth (Interim) Meeting of the Tenth Board of Directors- CFi.CN Zhongcai.com Post date April 19, 2022 — 20:10 Post Lock Read More Lukang Pharmaceutical (600789): Resolution of the 9th (Provisional) Meeting of the Tenth Supervisory Committee of Lukang Pharmaceutical- CFi.CN Zhongcai Network Post date April 19, 2022 — 20:10 Post Lock Read More Lukang Pharma (600789): Lukang Pharma's Explanation on the Revision of the Company's Adjustment of the Company's Allotment and Public Issuance of Securities Plan, Pre-plan, and Feasibility Analysis Report on the Use of Raised Funds- CFi.CN Zhongcai Network Post date April 19, 2022 — 20:10 Post Lock Read More Lukang Pharmaceutical (600789): Feasibility Analysis Report of Lukang Pharmaceutical's 2021 Annual Allotment Raised Funds (Revised Draft) CFi.CN Zhongcai Network Post date April 19, 2022 — 20:10 Post Lock Read More Lukang Pharmaceutical (600789): Lukang Pharmaceutical's Reply to the Feedback on the Allotment Application Documents (Revised Draft) CFi.CN Zhongcai Network Post date April 19, 2022 — 20:09 Post Lock Read More Lukang Pharmaceutical: Ceftriaxone Sodium for Injection Passes Consistency Evaluation of Generic Drugs Post date April 13, 2022 — 20:08 Post Lock Read More [Market] 1.6 billion oral hypoglycemic drugs, Lukang has reviewed it. Post date April 12, 2022 — 19:23 Post Lock Read More
The main trend: the net inflow of extra-large orders on May 10 was 7.117 billion yuan_Oriental Fortune Net Post date May 10, 2022 — 18:16 Post Lock Read More Lukang Pharmaceutical (600789.SH) net profit in the first quarter was 44.5889 million yuan, a year-on-year decrease of 7.02% – yqqlm Post date April 29, 2022 — 21:23 Post Lock Read More Lukang Pharmaceutical (600789.SH) net profit in the first quarter was 44.5889 million yuan, a year-on-year decrease of 7.02% Post date April 29, 2022 — 21:23 Post Lock Read More The net outflow of the pharmaceutical and biological industry today is 1.164 billion yuan, and the net outflow of 5 shares exceeds 100 million yuan_Oriental Fortune Net Post date April 27, 2022 — 17:37 Post Lock Read More 213 injection varieties have been "reviewed", and there are 100 varieties that meet the requirements of centralized procurement Post date April 27, 2022 — 15:02 Post Lock Read More Attention 250,000 shareholders! The last day of allotment, improper operation or loss! Stocks Financial World Post date April 20, 2022 — 12:38 Post Lock Read More Lukang Pharmaceutical (600789): Independent Opinions of Lukang Pharmaceutical Independent Directors on Matters Related to the Ninth (Interim) Meeting of the Tenth Board of Directors- CFi.CN Zhongcai.com Post date April 19, 2022 — 20:10 Post Lock Read More Lukang Pharmaceutical (600789): Resolution of the 9th (Provisional) Meeting of the Tenth Supervisory Committee of Lukang Pharmaceutical- CFi.CN Zhongcai Network Post date April 19, 2022 — 20:10 Post Lock Read More Lukang Pharma (600789): Lukang Pharma's Explanation on the Revision of the Company's Adjustment of the Company's Allotment and Public Issuance of Securities Plan, Pre-plan, and Feasibility Analysis Report on the Use of Raised Funds- CFi.CN Zhongcai Network Post date April 19, 2022 — 20:10 Post Lock Read More Lukang Pharmaceutical (600789): Feasibility Analysis Report of Lukang Pharmaceutical's 2021 Annual Allotment Raised Funds (Revised Draft) CFi.CN Zhongcai Network Post date April 19, 2022 — 20:10 Post Lock Read More Lukang Pharmaceutical (600789): Lukang Pharmaceutical's Reply to the Feedback on the Allotment Application Documents (Revised Draft) CFi.CN Zhongcai Network Post date April 19, 2022 — 20:09 Post Lock Read More Lukang Pharmaceutical: Ceftriaxone Sodium for Injection Passes Consistency Evaluation of Generic Drugs Post date April 13, 2022 — 20:08 Post Lock Read More [Market] 1.6 billion oral hypoglycemic drugs, Lukang has reviewed it. Post date April 12, 2022 — 19:23 Post Lock Read More
Lukang Pharmaceutical (600789.SH) net profit in the first quarter was 44.5889 million yuan, a year-on-year decrease of 7.02% – yqqlm Post date April 29, 2022 — 21:23 Post Lock Read More Lukang Pharmaceutical (600789.SH) net profit in the first quarter was 44.5889 million yuan, a year-on-year decrease of 7.02% Post date April 29, 2022 — 21:23 Post Lock Read More The net outflow of the pharmaceutical and biological industry today is 1.164 billion yuan, and the net outflow of 5 shares exceeds 100 million yuan_Oriental Fortune Net Post date April 27, 2022 — 17:37 Post Lock Read More 213 injection varieties have been "reviewed", and there are 100 varieties that meet the requirements of centralized procurement Post date April 27, 2022 — 15:02 Post Lock Read More Attention 250,000 shareholders! The last day of allotment, improper operation or loss! Stocks Financial World Post date April 20, 2022 — 12:38 Post Lock Read More Lukang Pharmaceutical (600789): Independent Opinions of Lukang Pharmaceutical Independent Directors on Matters Related to the Ninth (Interim) Meeting of the Tenth Board of Directors- CFi.CN Zhongcai.com Post date April 19, 2022 — 20:10 Post Lock Read More Lukang Pharmaceutical (600789): Resolution of the 9th (Provisional) Meeting of the Tenth Supervisory Committee of Lukang Pharmaceutical- CFi.CN Zhongcai Network Post date April 19, 2022 — 20:10 Post Lock Read More Lukang Pharma (600789): Lukang Pharma's Explanation on the Revision of the Company's Adjustment of the Company's Allotment and Public Issuance of Securities Plan, Pre-plan, and Feasibility Analysis Report on the Use of Raised Funds- CFi.CN Zhongcai Network Post date April 19, 2022 — 20:10 Post Lock Read More Lukang Pharmaceutical (600789): Feasibility Analysis Report of Lukang Pharmaceutical's 2021 Annual Allotment Raised Funds (Revised Draft) CFi.CN Zhongcai Network Post date April 19, 2022 — 20:10 Post Lock Read More Lukang Pharmaceutical (600789): Lukang Pharmaceutical's Reply to the Feedback on the Allotment Application Documents (Revised Draft) CFi.CN Zhongcai Network Post date April 19, 2022 — 20:09 Post Lock Read More Lukang Pharmaceutical: Ceftriaxone Sodium for Injection Passes Consistency Evaluation of Generic Drugs Post date April 13, 2022 — 20:08 Post Lock Read More [Market] 1.6 billion oral hypoglycemic drugs, Lukang has reviewed it. Post date April 12, 2022 — 19:23 Post Lock Read More
Lukang Pharmaceutical (600789.SH) net profit in the first quarter was 44.5889 million yuan, a year-on-year decrease of 7.02% Post date April 29, 2022 — 21:23 Post Lock Read More The net outflow of the pharmaceutical and biological industry today is 1.164 billion yuan, and the net outflow of 5 shares exceeds 100 million yuan_Oriental Fortune Net Post date April 27, 2022 — 17:37 Post Lock Read More 213 injection varieties have been "reviewed", and there are 100 varieties that meet the requirements of centralized procurement Post date April 27, 2022 — 15:02 Post Lock Read More Attention 250,000 shareholders! The last day of allotment, improper operation or loss! Stocks Financial World Post date April 20, 2022 — 12:38 Post Lock Read More Lukang Pharmaceutical (600789): Independent Opinions of Lukang Pharmaceutical Independent Directors on Matters Related to the Ninth (Interim) Meeting of the Tenth Board of Directors- CFi.CN Zhongcai.com Post date April 19, 2022 — 20:10 Post Lock Read More Lukang Pharmaceutical (600789): Resolution of the 9th (Provisional) Meeting of the Tenth Supervisory Committee of Lukang Pharmaceutical- CFi.CN Zhongcai Network Post date April 19, 2022 — 20:10 Post Lock Read More Lukang Pharma (600789): Lukang Pharma's Explanation on the Revision of the Company's Adjustment of the Company's Allotment and Public Issuance of Securities Plan, Pre-plan, and Feasibility Analysis Report on the Use of Raised Funds- CFi.CN Zhongcai Network Post date April 19, 2022 — 20:10 Post Lock Read More Lukang Pharmaceutical (600789): Feasibility Analysis Report of Lukang Pharmaceutical's 2021 Annual Allotment Raised Funds (Revised Draft) CFi.CN Zhongcai Network Post date April 19, 2022 — 20:10 Post Lock Read More Lukang Pharmaceutical (600789): Lukang Pharmaceutical's Reply to the Feedback on the Allotment Application Documents (Revised Draft) CFi.CN Zhongcai Network Post date April 19, 2022 — 20:09 Post Lock Read More Lukang Pharmaceutical: Ceftriaxone Sodium for Injection Passes Consistency Evaluation of Generic Drugs Post date April 13, 2022 — 20:08 Post Lock Read More [Market] 1.6 billion oral hypoglycemic drugs, Lukang has reviewed it. Post date April 12, 2022 — 19:23 Post Lock Read More
The net outflow of the pharmaceutical and biological industry today is 1.164 billion yuan, and the net outflow of 5 shares exceeds 100 million yuan_Oriental Fortune Net Post date April 27, 2022 — 17:37 Post Lock Read More 213 injection varieties have been "reviewed", and there are 100 varieties that meet the requirements of centralized procurement Post date April 27, 2022 — 15:02 Post Lock Read More Attention 250,000 shareholders! The last day of allotment, improper operation or loss! Stocks Financial World Post date April 20, 2022 — 12:38 Post Lock Read More Lukang Pharmaceutical (600789): Independent Opinions of Lukang Pharmaceutical Independent Directors on Matters Related to the Ninth (Interim) Meeting of the Tenth Board of Directors- CFi.CN Zhongcai.com Post date April 19, 2022 — 20:10 Post Lock Read More Lukang Pharmaceutical (600789): Resolution of the 9th (Provisional) Meeting of the Tenth Supervisory Committee of Lukang Pharmaceutical- CFi.CN Zhongcai Network Post date April 19, 2022 — 20:10 Post Lock Read More Lukang Pharma (600789): Lukang Pharma's Explanation on the Revision of the Company's Adjustment of the Company's Allotment and Public Issuance of Securities Plan, Pre-plan, and Feasibility Analysis Report on the Use of Raised Funds- CFi.CN Zhongcai Network Post date April 19, 2022 — 20:10 Post Lock Read More Lukang Pharmaceutical (600789): Feasibility Analysis Report of Lukang Pharmaceutical's 2021 Annual Allotment Raised Funds (Revised Draft) CFi.CN Zhongcai Network Post date April 19, 2022 — 20:10 Post Lock Read More Lukang Pharmaceutical (600789): Lukang Pharmaceutical's Reply to the Feedback on the Allotment Application Documents (Revised Draft) CFi.CN Zhongcai Network Post date April 19, 2022 — 20:09 Post Lock Read More Lukang Pharmaceutical: Ceftriaxone Sodium for Injection Passes Consistency Evaluation of Generic Drugs Post date April 13, 2022 — 20:08 Post Lock Read More [Market] 1.6 billion oral hypoglycemic drugs, Lukang has reviewed it. Post date April 12, 2022 — 19:23 Post Lock Read More
213 injection varieties have been "reviewed", and there are 100 varieties that meet the requirements of centralized procurement Post date April 27, 2022 — 15:02 Post Lock Read More Attention 250,000 shareholders! The last day of allotment, improper operation or loss! Stocks Financial World Post date April 20, 2022 — 12:38 Post Lock Read More Lukang Pharmaceutical (600789): Independent Opinions of Lukang Pharmaceutical Independent Directors on Matters Related to the Ninth (Interim) Meeting of the Tenth Board of Directors- CFi.CN Zhongcai.com Post date April 19, 2022 — 20:10 Post Lock Read More Lukang Pharmaceutical (600789): Resolution of the 9th (Provisional) Meeting of the Tenth Supervisory Committee of Lukang Pharmaceutical- CFi.CN Zhongcai Network Post date April 19, 2022 — 20:10 Post Lock Read More Lukang Pharma (600789): Lukang Pharma's Explanation on the Revision of the Company's Adjustment of the Company's Allotment and Public Issuance of Securities Plan, Pre-plan, and Feasibility Analysis Report on the Use of Raised Funds- CFi.CN Zhongcai Network Post date April 19, 2022 — 20:10 Post Lock Read More Lukang Pharmaceutical (600789): Feasibility Analysis Report of Lukang Pharmaceutical's 2021 Annual Allotment Raised Funds (Revised Draft) CFi.CN Zhongcai Network Post date April 19, 2022 — 20:10 Post Lock Read More Lukang Pharmaceutical (600789): Lukang Pharmaceutical's Reply to the Feedback on the Allotment Application Documents (Revised Draft) CFi.CN Zhongcai Network Post date April 19, 2022 — 20:09 Post Lock Read More Lukang Pharmaceutical: Ceftriaxone Sodium for Injection Passes Consistency Evaluation of Generic Drugs Post date April 13, 2022 — 20:08 Post Lock Read More [Market] 1.6 billion oral hypoglycemic drugs, Lukang has reviewed it. Post date April 12, 2022 — 19:23 Post Lock Read More
Attention 250,000 shareholders! The last day of allotment, improper operation or loss! Stocks Financial World Post date April 20, 2022 — 12:38 Post Lock Read More Lukang Pharmaceutical (600789): Independent Opinions of Lukang Pharmaceutical Independent Directors on Matters Related to the Ninth (Interim) Meeting of the Tenth Board of Directors- CFi.CN Zhongcai.com Post date April 19, 2022 — 20:10 Post Lock Read More Lukang Pharmaceutical (600789): Resolution of the 9th (Provisional) Meeting of the Tenth Supervisory Committee of Lukang Pharmaceutical- CFi.CN Zhongcai Network Post date April 19, 2022 — 20:10 Post Lock Read More Lukang Pharma (600789): Lukang Pharma's Explanation on the Revision of the Company's Adjustment of the Company's Allotment and Public Issuance of Securities Plan, Pre-plan, and Feasibility Analysis Report on the Use of Raised Funds- CFi.CN Zhongcai Network Post date April 19, 2022 — 20:10 Post Lock Read More Lukang Pharmaceutical (600789): Feasibility Analysis Report of Lukang Pharmaceutical's 2021 Annual Allotment Raised Funds (Revised Draft) CFi.CN Zhongcai Network Post date April 19, 2022 — 20:10 Post Lock Read More Lukang Pharmaceutical (600789): Lukang Pharmaceutical's Reply to the Feedback on the Allotment Application Documents (Revised Draft) CFi.CN Zhongcai Network Post date April 19, 2022 — 20:09 Post Lock Read More Lukang Pharmaceutical: Ceftriaxone Sodium for Injection Passes Consistency Evaluation of Generic Drugs Post date April 13, 2022 — 20:08 Post Lock Read More [Market] 1.6 billion oral hypoglycemic drugs, Lukang has reviewed it. Post date April 12, 2022 — 19:23 Post Lock Read More
Lukang Pharmaceutical (600789): Independent Opinions of Lukang Pharmaceutical Independent Directors on Matters Related to the Ninth (Interim) Meeting of the Tenth Board of Directors- CFi.CN Zhongcai.com Post date April 19, 2022 — 20:10 Post Lock Read More Lukang Pharmaceutical (600789): Resolution of the 9th (Provisional) Meeting of the Tenth Supervisory Committee of Lukang Pharmaceutical- CFi.CN Zhongcai Network Post date April 19, 2022 — 20:10 Post Lock Read More Lukang Pharma (600789): Lukang Pharma's Explanation on the Revision of the Company's Adjustment of the Company's Allotment and Public Issuance of Securities Plan, Pre-plan, and Feasibility Analysis Report on the Use of Raised Funds- CFi.CN Zhongcai Network Post date April 19, 2022 — 20:10 Post Lock Read More Lukang Pharmaceutical (600789): Feasibility Analysis Report of Lukang Pharmaceutical's 2021 Annual Allotment Raised Funds (Revised Draft) CFi.CN Zhongcai Network Post date April 19, 2022 — 20:10 Post Lock Read More Lukang Pharmaceutical (600789): Lukang Pharmaceutical's Reply to the Feedback on the Allotment Application Documents (Revised Draft) CFi.CN Zhongcai Network Post date April 19, 2022 — 20:09 Post Lock Read More Lukang Pharmaceutical: Ceftriaxone Sodium for Injection Passes Consistency Evaluation of Generic Drugs Post date April 13, 2022 — 20:08 Post Lock Read More [Market] 1.6 billion oral hypoglycemic drugs, Lukang has reviewed it. Post date April 12, 2022 — 19:23 Post Lock Read More
Lukang Pharmaceutical (600789): Resolution of the 9th (Provisional) Meeting of the Tenth Supervisory Committee of Lukang Pharmaceutical- CFi.CN Zhongcai Network Post date April 19, 2022 — 20:10 Post Lock Read More Lukang Pharma (600789): Lukang Pharma's Explanation on the Revision of the Company's Adjustment of the Company's Allotment and Public Issuance of Securities Plan, Pre-plan, and Feasibility Analysis Report on the Use of Raised Funds- CFi.CN Zhongcai Network Post date April 19, 2022 — 20:10 Post Lock Read More Lukang Pharmaceutical (600789): Feasibility Analysis Report of Lukang Pharmaceutical's 2021 Annual Allotment Raised Funds (Revised Draft) CFi.CN Zhongcai Network Post date April 19, 2022 — 20:10 Post Lock Read More Lukang Pharmaceutical (600789): Lukang Pharmaceutical's Reply to the Feedback on the Allotment Application Documents (Revised Draft) CFi.CN Zhongcai Network Post date April 19, 2022 — 20:09 Post Lock Read More Lukang Pharmaceutical: Ceftriaxone Sodium for Injection Passes Consistency Evaluation of Generic Drugs Post date April 13, 2022 — 20:08 Post Lock Read More [Market] 1.6 billion oral hypoglycemic drugs, Lukang has reviewed it. Post date April 12, 2022 — 19:23 Post Lock Read More
Lukang Pharma (600789): Lukang Pharma's Explanation on the Revision of the Company's Adjustment of the Company's Allotment and Public Issuance of Securities Plan, Pre-plan, and Feasibility Analysis Report on the Use of Raised Funds- CFi.CN Zhongcai Network Post date April 19, 2022 — 20:10 Post Lock Read More Lukang Pharmaceutical (600789): Feasibility Analysis Report of Lukang Pharmaceutical's 2021 Annual Allotment Raised Funds (Revised Draft) CFi.CN Zhongcai Network Post date April 19, 2022 — 20:10 Post Lock Read More Lukang Pharmaceutical (600789): Lukang Pharmaceutical's Reply to the Feedback on the Allotment Application Documents (Revised Draft) CFi.CN Zhongcai Network Post date April 19, 2022 — 20:09 Post Lock Read More Lukang Pharmaceutical: Ceftriaxone Sodium for Injection Passes Consistency Evaluation of Generic Drugs Post date April 13, 2022 — 20:08 Post Lock Read More [Market] 1.6 billion oral hypoglycemic drugs, Lukang has reviewed it. Post date April 12, 2022 — 19:23 Post Lock Read More
Lukang Pharmaceutical (600789): Feasibility Analysis Report of Lukang Pharmaceutical's 2021 Annual Allotment Raised Funds (Revised Draft) CFi.CN Zhongcai Network Post date April 19, 2022 — 20:10 Post Lock Read More Lukang Pharmaceutical (600789): Lukang Pharmaceutical's Reply to the Feedback on the Allotment Application Documents (Revised Draft) CFi.CN Zhongcai Network Post date April 19, 2022 — 20:09 Post Lock Read More Lukang Pharmaceutical: Ceftriaxone Sodium for Injection Passes Consistency Evaluation of Generic Drugs Post date April 13, 2022 — 20:08 Post Lock Read More [Market] 1.6 billion oral hypoglycemic drugs, Lukang has reviewed it. Post date April 12, 2022 — 19:23 Post Lock Read More
Lukang Pharmaceutical (600789): Lukang Pharmaceutical's Reply to the Feedback on the Allotment Application Documents (Revised Draft) CFi.CN Zhongcai Network Post date April 19, 2022 — 20:09 Post Lock Read More Lukang Pharmaceutical: Ceftriaxone Sodium for Injection Passes Consistency Evaluation of Generic Drugs Post date April 13, 2022 — 20:08 Post Lock Read More [Market] 1.6 billion oral hypoglycemic drugs, Lukang has reviewed it. Post date April 12, 2022 — 19:23 Post Lock Read More
Lukang Pharmaceutical: Ceftriaxone Sodium for Injection Passes Consistency Evaluation of Generic Drugs Post date April 13, 2022 — 20:08 Post Lock Read More [Market] 1.6 billion oral hypoglycemic drugs, Lukang has reviewed it. Post date April 12, 2022 — 19:23 Post Lock Read More
[Market] 1.6 billion oral hypoglycemic drugs, Lukang has reviewed it. Post date April 12, 2022 — 19:23 Post Lock Read More
Caishen.CoCaishen.Co